openPR Logo
Press release

Antiviral Drug Resistance Market 2027 Key Technology Development Covering Immunodiagnostics, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS]

11-05-2019 06:32 AM CET | Science & Education

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

Global Antiviral Drug Resistance Market is projected to grow at a CAGR of 6.8% during the period 2019-2027. The report is serviceable to various stakeholders engaged in the target market. It offers a global view of estimates and forecasts on market size, share, industry trends, and future market potential.

The market for antiviral drug resistance is foreseen to garner high demand on account of rising incidences of hepatitis diseases coupled with the increasing prevalence of HIV/AIDS. The global Antiviral Drug Resistance market is forecasted to reach US$ 4,573.2 Mn in 2027 from US$ 2,572.3 Mn in 2018. The increasing healthcare expenditures in emerging markets are further positively contributing to the growth of the antiviral drug resistance market in the years to come.

Regional Overview
The report offers exclusive insights into the Antiviral Drug Resistance market for eighteen countries. It covers five major geographical regions North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America (S&CAM) along with their exhaustive PEST analysis.
The rapid growth and innovations taking place in the emerging nations are awaited to boost both growth opportunities and sales in the global antiviral drug resistance market. Increasing healthcare expenditures in Asia Pacific and South and Central America are facilitating researchers to develop treatment options for a wide range of viral diseases using PCR (Polymerase Chain Reaction) and other advanced techniques such as next-generation sequencing.

Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00006395?utm_source=OpenPR&utm_medium=Simran

Segmentation
The market study for global Antiviral Drug Resistance is segmented by Product, Disease Indication, Technology, and End User. Based on the product, the segmentation is done as Kits & Reagents and Instruments. By disease indication, the Antiviral Drug Resistance market is segmented as Human Immunodeficiency Virus [HIV], Hepatitis, and Cytomegalovirus [CMV]. The market by technology is segmented as Immunodiagnostics, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS], and Others. On the other hand, the end user market is segmented as Hospitals & Clinics, Pathology or Diagnostic Laboratories and Research Institutes.

Key Players
The report profiles some top companies in the Antiviral Drug Resistance market, giving necessary information on their product offerings, financial overview, SWOT analysis, and market-specific developments. Key players mentioned in the report are Danaher, AccuBioTech Co., Ltd., Abbott, BD, F. Hoffmann-La Roche Ltd, Trinity Biotech, Seimens AG, bioMérieux SA, Bio-Rad Laboratories, Inc, and ACON Laboratories, Inc.

Industry news
The key players of the Antiviral Drug Resistance market are adopting organic and inorganic growth strategies. For instance, Roche recently expanded its Global Access Program beyond HIV, to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low and middle-income country programs. The report mentions several other initiatives and developments for stakeholders toward a better understanding of the market and strategic decision-making.

Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00006395?utm_source=OpenPR&utm_medium=Simran

Contact us –
Phone : +1-646-491-9876
Email Id : sales@theinsightpartners.com
Website: https://www.theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiviral Drug Resistance Market 2027 Key Technology Development Covering Immunodiagnostics, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS] here

News-ID: 1861036 • Views: 144

More Releases from The Insight Partners

Artificial Intelligence in Supply Chain Market Outlook to 2027 with Top Key Play …
“Worldwide Artificial Intelligence in Supply Chain Market Analysis 2019-2027″ is a specialized and in-depth study of the technology industry focusing on the global market trend. The report aims to provide an overview of the global Artificial Intelligence in Supply Chain Market with detailed market segmentation by type, application and geography. The global market for Artificial Intelligence in Supply Chain Market is expected to grow strongly in the forecasting period. The
Cognitive Robotic Process Automation Market Future Trends to 2027 - IPsoft, Veri …
According to a new market study entitled "Cognitive Robotic Process Automation Market to 2027 - Global Analysis and Forecasts by Deployment Type (On-Premise and Cloud) and Industry Vertical (BFSI, Healthcare & Life Sciences, Retail & Consumer Goods, Manufacturing, Travel & Hospitality, IT & Telecommunication, Media & Entertainment, and Others) and Geography, "explains the report, explaining the key drivers of this growth and highlighting key market players and their evolution. The
Allergy Immunotherapy Market Competitive Dynamics and Business Outlook 2027 | Ci …
Allergy Immunotherapy Market: Introduction and Dynamics Allergy Immunotherapy Market concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in the report that may affect the market in near future. Segmentation of the market are studied specifically to give profound knowledge for supplementary market investments. The report aims to provide an overview of
Generic Drugs Market 2019 Statistic Competitive Landscape Forecast to 2027 With …
The “The Insight Partners “ market research report provides a comprehensive picture on “Generic Drugs Market”, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete research and development history, latest news and press releases. Furthermore, the study explains the future opportunities and a sketch of key players operating in the “Generic Drugs

All 5 Releases


More Releases for Antiviral

Asia Pacific Antiviral Drug Market – Trends, Growth & Forecasts (2018 – 2024 …
Summary of the Report: “Asia Pacific Antiviral Drug Market study by Envision Inteligence discusses in detail about diverse market dynamics influencing the market and covers the leading market players and competitive highlights and trends prevailing over the years". The report "ASIA PACIFIC ANTIVIRAL DRUG MARKET," is expected to reach USD XX Billion by the year 2024, at a CAGR of 4.99% during forecast period. Antiviral Drugs are medicines which are used for
North America Antiviral Drug Market – Trends, Growth & Forecasts (2018 – 202 …
The report "NORTH AMERICA ANTIVIRAL DRUG MARKET," is expected to reach USD XX Billion by the year 2024, at a CAGR of XX% during forecast period. Antiviral Drugs are medicines which are used for treating viral infections. Most anti-viral drugs are used for particular viral infections, similar to antibiotics, while a broad-spectrum anti-viral drug is effective against a varied range of viruses. Antiviral drugs do not kill their target pathogen,
Europe Antiviral Drug Market – Trends, Growth & Forecasts (2018 – 2024)
The report "EUROPE ANTIVIRAL DRUG MARKET," the Europe Antiviral Drug market is expected to reach USD XX Billion by the year 2024, at a CAGR of 4.99% during forecast period. Antiviral Drugs are medicines which are used for treating viral infections. Most anti-viral drugs are used for particular viral infections, similar to antibiotics, while a broad-spectrum anti-viral drug is effective against a varied range of viruses. Antiviral drugs do
Antiviral Immunoglobulin Market to Incur Rapid Extension During 2027
Immunoglobulin's also called as Antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Antiviral immunoglobulin is used for the prevention of lower respiratory tract infections, prevention of re-infection with HCV, treatments of diseases caused by the vaccinia virus, treatment of rare adverse reactions to smallpox vaccination,
Antiviral Drugs Market Research Report by Key Players Analysis 2024
The global antivirus drugs market is likely to exhibit a solid CAGR of 6.40% between 2016 and 2024. The market’s valuation is expected to rise from US$48.3 bn to US$82.9 bn over the forecast period. The global antiviral drugs market is segmented by region into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Developed countries in North America and Europe are likely to play a key
North America Antiviral Drugs Market - Preventive methods and Market Trends
Market Data Forecast recently published a report on the “North America Antiviral Drugs Market” which estimates the market to grow from USD 9.91 billion from 2016 to USD 12.34 billion with a high CAGR of 4.47%. Antiviral Drugs helps in combating viral infections by hampering the replication of viruses and strengthening the immune response to the viral infection. From the past few years resistance is observed among viruses against different antiviral